Companies: 10,795·Total market cap: $144.5T
Chemed Corporation

Chemed Corporation

CHENYSEHealthcare● Active
$440.15
$-1.44(-0.33%)
Market Cap$5.8B
P/E Ratio—
52W High$565.66
52W Low$365.21
Overview

Chemed Corporation (CHE) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CHE · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$74.5M▼ -58.2% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$74.5M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-58.2%
vs prior fiscal year
Latest Quarter
$16.9M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$74.5MCash on Hand
Total Debt$154.8MTotal Debt
Net Cash / Net Debt−$80.2MNet Debt Position
Cash vs Debt Ratio
Cash 33%Debt 67%

Chemed Corporation carries a net debt position of $80.2M. Total debt ($154.8M) exceeds cash on hand ($74.5M). Chemed Corporation cash vs debt ratio: 33% cash / 67% debt.

Net Cash = Cash & ST Investments − Total Debt$74.5M − $154.8M = −$80.2M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CHE annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$74.5M-58.2%
Dec 31, 2024$178.3M-32.4%
Dec 31, 2023$264.0M+256.1%
Dec 31, 2022$74.1M+125.3%
Dec 31, 2021$32.9M-79.8%
CHE cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Chemed Corporation
Chemed CorporationYOU
CHE
$74.5M1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Chemed Corporation (CHE) cash on hand as of December 31, 2025 is $74.5M, comprising $74.5M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Chemed Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Chemed Corporation cash reserves or cash position.

Chemed Corporation annual cash on hand history shows decreased -58.2% in 2025: decreased -58.2% in 2025. Chemed Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Chemed Corporation carries total debt of $154.8M against cash of $74.5M, resulting in a net debt position of -$80.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

CHE cash on hand · 5 questions

As of December 31, 2025, Chemed Corporation (CHE) has $74,515,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $74,515,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $16,856,000. Data sourced from the annual 10-K filing via FMP.

CHE cash on handCHE cash reservesCHE cash 2025how much cash does CHE have

▸ Source: FMP /balance-sheet-statement · US GAAP · Chemed Corporation · Chemed Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025